BDBM123692 US8741907, 19
SMILES: CCC(CC)n1ncc2c1nc(CC1CCCCC1)[nH]c2=S
InChI Key: InChIKey=PHBFLKWXWNOHHC-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphodiesterase 9A (Homo sapiens (Human)) | BDBM123692 (US8741907, 19) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 390 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Boehringer Ingelheim International GmbH US Patent | Assay Description The test substances are dissolved in 100% DMSO and serially diluted to determine their in vitro effect on PDE 9A. 2 uL portions of the diluted substa... | US Patent US8741907 (2014) BindingDB Entry DOI: 10.7270/Q21V5CNH | |||||||||||
More data for this Ligand-Target Pair |